Onaiza Cadoret-Manier

Onaiza Cadoret-Manier is a board member at Ardelyx and was previously with Ionis Pharmaceuticals, Inc. From June 2018 to May 2019, they were the Chief Commercial Officer at GRAIL, Inc. where they led oncology commercial strategy and business model for early detection of multiple cancers. Prior to that, they were with Genentech USA, Inc. from March 2017 to May 2018 as the Head of Respiratory Franchise and from March 2011 to February 2017 as the VP Sales and Marketing for Esbriet - Rare Disease. Onaiza has also held the position of VP Portfolio Strategy & Pipeline Development at Amylin Pharmaceuticals from July 2007 to December 2011.

Onaiza Cadoret-Manier has an MBA in Marketing & Finance from the University of Chicago Booth School of Business, a BA in Economics and Accounting from Queens College, and an Executive MBA in Business from Harvard Business School. Onaiza is also certified by the NY State Board of Accountancy as a C.P.A.